113 related articles for article (PubMed ID: 6372264)
1. Metabolism of captopril-L-cysteine, a captopril metabolite, in rats and dogs.
Kripalani KJ; Dean AV; Migdalof BH
Xenobiotica; 1983 Dec; 13(12):701-5. PubMed ID: 6372264
[TBL] [Abstract][Full Text] [Related]
2. Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.
Park BK; Grabowski PS; Yeung JH; Breckenridge AM
Biochem Pharmacol; 1982 May; 31(9):1755-60. PubMed ID: 7049181
[TBL] [Abstract][Full Text] [Related]
3. Drug-protein conjugates--IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat.
Yeung JH; Breckenridge AM; Park BK
Biochem Pharmacol; 1983 Sep; 32(17):2467-72. PubMed ID: 6351864
[TBL] [Abstract][Full Text] [Related]
4. Captopril: pharmacology, metabolism and disposition.
Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
Matsumoto K; Miyazaki H; Fujii T; Yoshida K; Amejima H; Hashimoto M
Arzneimittelforschung; 1986; 36(1):40-6. PubMed ID: 3513776
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
8. The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
Wood SG; John BA; Chasseaud LF; Johnstone I; Biggs SR; Hawkins DR; Priego JG; Darragh A; Lambe RF
Xenobiotica; 1983 Dec; 13(12):731-42. PubMed ID: 6144210
[TBL] [Abstract][Full Text] [Related]
9. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans.
Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA
Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of captopril in dogs and monkeys.
Singhvi SM; Peterson AE; Ross JJ; Shaw JM; Keim GR; Migdalof BH
J Pharm Sci; 1981 Oct; 70(10):1108-12. PubMed ID: 7028947
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on the metabolic pathway of SQ 14225 (Captopril) and mechanism of mixed disulfide formation.
Komai T; Ikeda T; Kawai K; Kameyama E; Shindo H
J Pharmacobiodyn; 1981 Sep; 4(9):677-84. PubMed ID: 7038090
[TBL] [Abstract][Full Text] [Related]
13. Drug protein conjugates--VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates.
Yeung JH; Breckenridge AM; Park BK
Biochem Pharmacol; 1983 Dec; 32(23):3619-25. PubMed ID: 6360177
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration.
Heald AF; Ita CE; Singhvi SM; Migdalof BH
Xenobiotica; 1985 Jan; 15(1):51-6. PubMed ID: 3885586
[TBL] [Abstract][Full Text] [Related]
15. In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans.
Wong KK; Lan S; Migdalof BH
Biochem Pharmacol; 1981 Oct; 30(19):2643-50. PubMed ID: 7028042
[No Abstract] [Full Text] [Related]
16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
17. Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.
Breda M; Benedetti MS; Battaglia R; Castelli MG; Poggesi I; Spinelli R; Hackett AM; Dostert P
Pharmacol Res; 2000 Feb; 41(2):239-48. PubMed ID: 10623492
[TBL] [Abstract][Full Text] [Related]
18. Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat.
Drummer OH; Jarrott B
Biochem Pharmacol; 1984 Nov; 33(22):3567-71. PubMed ID: 6095854
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
John BA; Chasseaud LF; Wood SG; Forlot P
Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
